Landscapes / Companies
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials · 13 in all
Trials
6 active
16 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in China | Jan 2027Phase 2 trial completes | |||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Port-wine Birthmarks, Port-Wine Stain and 1 more | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2029Phase 1 trial completes | |||
| Next date | Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced/ Metastatic Solid Tumors, Triple Negative Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced and Metastatic Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Dec 2027Phase 1 trial completes | |||
| Next date | 1 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma), High Grade Glioma (III or IV) and 2 more | ||||
| Open drug page | |||||
About
- No active trial
- 9 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021